Lilly to Separate Elanco Animal Health with Initial Public Offering

24-Jul-2018 (1 months 30 days ago)
Elanco

Eli Lilly and Company today announced that the company has completed its strategic review of Elanco Animal Health, and will file a registration statement in the coming weeks with the U.S. Securities and Exchange Commission (SEC) for a potential initial public offering (IPO) of a minority ownership stake in Elanco as a separate company.

Lilly to Separate Elanco Animal Health with Initial Public Offering